recombinant human interleukin-10
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant human interleukin-10, covering 2008-03-04 to 2008-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis [Phase 2]